Articles
Showing 1–12 of 167 resultsSorted by latest
-
Canada’s medication spending has been relatively low; may need to be reconsidered because of US “most-favored nation” pharma pricing policy
Read more -
Does Canada pay its fair share of the global cost of pharmaceutical innovation?
Read more -
The Economic Burden of Seasonal Influenza in Quebec: Updated Estimates and Policy Implications
Read more -
Bulk purchasing for innovative pharmaceuticals – proceed with caution
Read more -
Net direct expenditure on patented medicines by public drug plans in 10 Canadian provinces in 2023
Read more -
Documenting Long-Acting Reversible Contraceptive (LARC) Coverage Across Canada
Read more -
Judicial perspectives on the use of class action litigation as a tool for health policy change
Read more -
Access to new drugs on public formularies in 10 Canadian provinces 2019 to 2024
Read more -
The impact of pharmaceutical innovation on mortality and hospital utilization in Canada, 2000–2022
Read more -
Lessons from Abroad for Canada’s National Dementia Strategy: Actions for Implementation
Read more -
Insights and Opportunities into the State of Precision Oncology in Atlantic Canada Report
Read more -
Better Canadian Health Care Access and Outcomes Requires Moving Toward a Combined Salaried Public and Selected Private Physician Remuneration Model
Read more